Lisa Stiffler at Dateline Earth reports on the newest research on PBDEs (levels of this flame retardant in household dust correlate to levels in breast milk) and gives an update on Washington stateâs proposed PBDE ban.
Jake Young at Pure Pedantry has an update on Eli Lilly's attempts to block the online distribution of documents that show that the company tried to play down the side effects of its schizophrenia drug Zyprexa.
Mead Over at Global Health Policy commends the 22 Members of Congress who wrote to the US Trade Representative in support of Thailand's exercise of a compulsory license for the AIDS drug Efavirenz, and provides background and analysis on this issue.
Andrea Lynch at RH Reality Check reports on the contributions to the UN Population Fund and some of the programs those contributions will support; she notes that a certain country is conspicuously absent from the list of UNFPA supporters.
Aman at Technology, Health & Development reviews the debate on the relative importance of drug pricing and healthcare infrastructure in poor countries. (Hat tip to John, who posted a link to this blog in a comment on last Friday's Roundup.)
Zuska at Thus Spake Zuska reminds us that budding geeks need nurturing communities â and suggests the book âSheâs Such a Geek!â as one tool for getting more young women to consider careers in science.
Andrew Dessler of Gristmill brought his cogent message about science and policy to Capitol Hill.
RealClimate follows up on the controversy about NSTA and An Inconvenient Truth.
Laura Kahn at The Bulletin Online (website of the Bulletin of the Atomic Scientists) explores the concerns about of increased government oversight of basic life sciences research.